Cargando…

Offering HCV treatment to prisoners is an important opportunity: key principles based on policy and practice assessment in Europe

BACKGROUND: Prisoners have a high prevalence of hepatitis C virus (HCV) infection but may find it difficult to access healthcare services. This may be related to risk behaviour including history of injecting drugs and marginalisation related to problem drug use/ opioid use disorder (OUD). Direct-act...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stöver, H., Meroueh, F., Marco, A., Keppler, K., Saiz de la Hoya, P., Littlewood, R., Wright, N., Nava, F., Alam, F., Walcher, S., Somaini, L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6323720/ https://www.ncbi.nlm.nih.gov/pubmed/30621658 http://dx.doi.org/10.1186/s12889-018-6357-x

Ejemplares similares

Prisoners should not be left behind in HCV research and policies
por: Moazen, Babak, et al.
Publicado: (2020)

HCV Elimination in Central Europe with Particular Emphasis on Microelimination in Prisons
por: Flisiak, Robert, et al.
Publicado: (2022)

Personality disorders do not affect treatment outcomes for chronic HCV infection in Spanish prisoners: the Perseo study
por: Marco, Andrés, et al.
Publicado: (2015)

COVID-19 vaccination in prison settings: a model to design tailored vaccine delivery strategies: Lara Tavoschi
por: Tavoschi, L, et al.
Publicado: (2022)

Is HCV elimination possible in prison?
por: Crespo, J., et al.
Publicado: (2017)

Comment on: Should bariatric surgery be offered to prisoners?
por: Friedman, Danielle T., et al.
Publicado: (2020)

Principles of condom provision programs in prisons from the standpoint of European prison health experts: a qualitative study
por: Moazen, Babak, et al.
Publicado: (2021)

Burden of infectious diseases in prison settings and services offered: Filipa Alves da Costa
por: Alves da Costa, F
Publicado: (2022)

HCV infection and drug use in Italian detainees: results of validation of EQDP (European Questionnaire on Drug Use in Prison)
por: Felice, A. Nava
Publicado: (2018)

HIV and HCV among drug users and people living in prisons in Germany 2022: WHO elimination targets as reflected in practice
por: Stöver, H., et al.
Publicado: (2023)

Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C‐SCOPE Study
por: Litwin, Alain H., et al.
Publicado: (2019)

Opioid substitution therapy for people living in German prisons—inequality compared with civic sector
por: Stöver, Heino, et al.
Publicado: (2019)

OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis
por: Wright, Nat, et al.
Publicado: (2020)

Prevalence and Incidence of HCV Infection among Prisoners in Central Brazil
por: Puga, Marco Antonio Moreira, et al.
Publicado: (2017)

Telemedicine and specialised consultations in prisons. The example of HCV chronic hepatitis
por: Fernández Rodríguez, C, et al.
Publicado: (2019)

Monitoring health status of people living in prison in Europe: insights from HIPED
por: Alves da Costa, F
Publicado: (2023)

Integration of prison health care into national disease surveillance and health informatic systems: opportunities and challenges for Europe and beyond
por: O'Moore, E
Publicado: (2023)

Prison and opportunities for the management of COVID-19
por: Crowley, Des, et al.
Publicado: (2020)

A retrospective study to find the prevalence of HIV, HCV and dual HIV-HCV infection in the prison inmates
por: Singh, Gur Parkash, et al.
Publicado: (2022)

Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern
por: Michel, Laurent, et al.
Publicado: (2015)

Long-term condition management for prisoners: improving the processes between community and prison
por: Wright, NMJ, et al.
Publicado: (2021)

Initial Coin Offerings: Risk or Opportunity?
por: Toma, Anca Mirela, et al.
Publicado: (2020)

Roboethics principles and policies in Europe and North America
por: Langman, Sofya, et al.
Publicado: (2021)

841. Survey of Current HIV and HCV Policies and Practices in Prisons and Jails Serving High-Risk Geographic Hotspots
por: Min, Sugi, et al.
Publicado: (2021)

Opportunities for European Industry offered by the LEP Project
Publicado: (1981)

Deubiquitinases and the new therapeutic opportunities offered to cancer
por: Pfoh, Roland, et al.
Publicado: (2015)

HCV treatment in children and young adults with HIV/HCV co-infection in Europe
por: Turkova, Anna, et al.
Publicado: (2015)

HCV infected prisoners: should they be still considered a difficult to treat population?
por: Iacomi, Fabio, et al.
Publicado: (2013)

Prevalence and epidemiological correlates and treatment outcome of HCV infection in an Italian prison setting
por: Brandolini, Micaela, et al.
Publicado: (2013)

Evidence that Fgf10 offers therapeutic opportunities after hyperoxic lung injury in mice
por: Chao, CM, et al.
Publicado: (2014)

Editorial: Why Livestock Genomics for Developing Countries Offers Opportunities for Success
por: Muchadeyi, Farai C., et al.
Publicado: (2020)

New therapeutic options for HCV in Central Europe
por: Flisiak, Robert, et al.
Publicado: (2016)

Prevalence and associated risk factors of latent tuberculosis infection in a Spanish prison
por: López de Goicoechea-Saiz, ME, et al.
Publicado: (2018)

Drug use and opioid substitution treatment for prisoners
por: Stöver, Heino, et al.
Publicado: (2010)

Distribution of HCV Genotypes in the Populations of Inmates in Polish Prison Potulice and Patients Hospitalised in Bydgoszcz
por: Tyczyno, Malgorzata, et al.
Publicado: (2014)

Barriers and facilitators to hepatitis C (HCV) screening and treatment—a description of prisoners’ perspective
por: Crowley, Des, et al.
Publicado: (2018)

Novel opportunities and challenges offered by nanobiomaterials in tissue engineering
por: Gelain, Fabrizio
Publicado: (2008)

Social Security: Offering Welfare Opportunities for the Vulnerable People
por: SHRIVASTAVA, Saurabh, et al.
Publicado: (2014)

Targeting PRC2: RNA offers new opportunities
por: Wang, Xueyin, et al.
Publicado: (2017)

Porous organic materials offer vast future opportunities
por: Liu, Tianyu, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5jvna7ds2usoljup1hivfn7bg3